Sisram Medical Ltd (HKG:1696)
3.440
+0.080 (2.38%)
At close: Mar 27, 2026
Sisram Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 70.97 | 70.23 | 70.6 | 81.55 | 153.06 |
Short-Term Investments | - | 2.18 | 0.7 | 9.95 | 4.9 |
Trading Asset Securities | - | 1.75 | - | - | - |
Cash & Short-Term Investments | 70.97 | 74.16 | 71.3 | 91.49 | 157.96 |
Cash Growth | -4.29% | 4.01% | -22.07% | -42.08% | 32.65% |
Accounts Receivable | 92.59 | 80.76 | 83.46 | 80.38 | 69.88 |
Other Receivables | - | 3.78 | 10.8 | - | - |
Receivables | 92.59 | 84.54 | 94.25 | 80.38 | 69.88 |
Inventory | 93.29 | 81.02 | 80.55 | 74.72 | 64.24 |
Prepaid Expenses | 18.71 | 3.02 | 4.29 | - | - |
Other Current Assets | 0.73 | 6.49 | 6.96 | 3.97 | 5.53 |
Total Current Assets | 276.29 | 249.21 | 257.35 | 250.57 | 297.6 |
Property, Plant & Equipment | 56.79 | 59.47 | 62.91 | 52.2 | 45.46 |
Long-Term Investments | 10.12 | 7.92 | 6.16 | 16.41 | 7.17 |
Goodwill | 126.92 | 126.92 | 126.92 | 111.18 | 111.18 |
Other Intangible Assets | 136.7 | 142.54 | 136.07 | 45.29 | 51.22 |
Long-Term Accounts Receivable | 35.92 | 26.55 | 12.91 | 13.05 | 12.55 |
Long-Term Deferred Tax Assets | 9.95 | 9.62 | 9.94 | 7.25 | 4.7 |
Other Long-Term Assets | 4.57 | 5.03 | 1.26 | 59.66 | 0.25 |
Total Assets | 657.26 | 627.26 | 613.5 | 555.6 | 530.13 |
Accounts Payable | 22.93 | 13.36 | 8 | 13.34 | 13.02 |
Accrued Expenses | - | 43.36 | 41.13 | 39.56 | 39.6 |
Short-Term Debt | 10.79 | 4.8 | 4.42 | 5.74 | 7.29 |
Current Portion of Leases | 5.5 | 4.41 | 4.72 | 2.88 | 3.09 |
Current Income Taxes Payable | 4.7 | 8.88 | 4.92 | 1.83 | 4.06 |
Current Unearned Revenue | 12.04 | 15.6 | 15.9 | 14.38 | 15.04 |
Other Current Liabilities | 50.3 | 5.09 | 9.15 | 2.41 | 1.45 |
Total Current Liabilities | 106.25 | 95.49 | 88.25 | 80.13 | 83.56 |
Long-Term Leases | 35.46 | 34 | 35.54 | 32.72 | 31.24 |
Long-Term Unearned Revenue | 3.46 | 1.25 | 0.85 | 0.59 | 0.26 |
Pension & Post-Retirement Benefits | - | 1.32 | 1.22 | 1.06 | 1.72 |
Long-Term Deferred Tax Liabilities | 7.21 | 8.67 | 14.36 | 8.65 | 9.41 |
Other Long-Term Liabilities | 1.19 | 1.74 | 3.76 | 0.24 | 0.32 |
Total Liabilities | 153.58 | 142.47 | 143.98 | 123.38 | 126.51 |
Common Stock | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
Additional Paid-In Capital | - | 323.07 | 323.07 | 321.53 | 319.87 |
Retained Earnings | - | 171.77 | 156.33 | 135.63 | 104.25 |
Comprehensive Income & Other | 478.52 | -32.14 | -28.42 | -27.62 | -23.26 |
Total Common Equity | 479.85 | 464.03 | 452.31 | 430.87 | 402.18 |
Minority Interest | 23.83 | 20.76 | 17.21 | 1.35 | 1.44 |
Shareholders' Equity | 503.68 | 484.79 | 469.53 | 432.23 | 403.63 |
Total Liabilities & Equity | 657.26 | 627.26 | 613.5 | 555.6 | 530.13 |
Total Debt | 51.75 | 43.2 | 44.68 | 41.34 | 41.62 |
Net Cash (Debt) | 19.22 | 30.95 | 26.62 | 50.15 | 116.34 |
Net Cash Growth | -37.91% | 16.29% | -46.93% | -56.89% | 41.85% |
Net Cash Per Share | 0.04 | 0.07 | 0.06 | 0.11 | 0.26 |
Filing Date Shares Outstanding | 468.34 | 468.34 | 468.34 | 467.29 | 466.16 |
Total Common Shares Outstanding | 468.34 | 468.34 | 468.34 | 467.29 | 466.16 |
Working Capital | 170.04 | 153.73 | 169.1 | 170.44 | 214.04 |
Book Value Per Share | 1.02 | 0.99 | 0.97 | 0.92 | 0.86 |
Tangible Book Value | 216.24 | 194.57 | 189.33 | 274.4 | 239.78 |
Tangible Book Value Per Share | 0.46 | 0.42 | 0.40 | 0.59 | 0.51 |
Machinery | - | 21.75 | 20.42 | 17.64 | 13.15 |
Leasehold Improvements | - | 17.44 | 16.04 | 9.9 | 9.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.